Jakub Zadykowicz
Research Subjects
Jakub Zadykowicz has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Artur Ciszewski
Independent Public Health Care Center in Sokolka
2 shared publications - Dominika Strzalińska
University Clinical Hospital In Bialystok: Bialystok
2 shared publications - Julia Bajko
Department of Urology and Oncological Urology, Faculty of Medicine, Medical University of Bialystok, Jana Kilinskiego 1, 15-089 Bialystok, Poland
2 shared publications - Juliusz Błażewicz
Dr Ludwik Rydygier Voivodeship Hospital in Suwalki
2 shared publications - Kinga Kapusta
Dr Ludwik Rydygier Voivodeship Hospital in Suwalki
2 shared publications - Klaudia Pazio
Dr Ludwik Rydygier Voivodeship Hospital in Suwalki
2 shared publications
Latest Publications
- Open Access
- 31 May 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 56
The Effects of Physical Activity and Structured Exercise on Metabolic Health and Cardiovascular Risk: A Comprehensive Review
Background:Cardiovascular diseases (CVDs) remain the leading global cause of mortality and are increasingly recognised as a systemic metabolic–inflammatory disorder. Physical inactivity is a major modifiable risk factor, while regular physical activity is associated with broad cardiometabolic benefits. Methods:This narrative review synthesises evidence from meta-analyses, randomised controlled trials, and mechanistic studies identified through PubMed, Scopus, Web of Science, and JACC. Studies evaluating aerobic, resistance, combined, and high-intensity interval training (HIIT) were included. Outcomes included cardiovascular risk factors, inflammation, metabolic health, cardiorespiratory fitness, and clinical endpoints. Results:Regular physical activity reduces systemic inflammation (CRP, IL-6, TNF-α), improves endothelial function, and enhances insulin sensitivity. Combined aerobic and resistance training provides superior improvements in glycaemic control, including HbA1c reductions (~0.5%), fasting glucose, and lipid profiles compared with single-modality exercise. Clinically relevant reductions in blood pressure are observed, particularly in hypertensive populations (systolic ~5–10 mmHg). Exercise improves lipid profiles (↑HDL, ↓LDL and triglycerides) and reduces visceral fat (~7–20%). Improvements in VO₂ peak are strongly associated with reduced cardiovascular morbidity and mortality. A dose–response relationship is evident, with optimal benefits at 150–300 min/week of moderate-intensity activity. Sedentary behaviour independently increases cardiovascular risk. Despite benefits, adherence remains suboptimal, although digital tools and personalised interventions improve compliance. Conclusion:Physical activity is a cornerstone of cardiovascular disease prevention and management, improving metabolic, inflammatory, and haemodynamic health. Individualised and technology-supported exercise strategies may enhance long-term adherence and maximise clinical benefit.
- 31 May 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 56
Open AccessThe Effects of Physical Activity and Structured Exercise on Metabolic Health and Cardiovascular Risk: A Comprehensive Review
Background:Cardiovascular diseases (CVDs) remain the leading global cause of mortality and are increasingly recognised as a systemic metabolic–inflammatory disorder. Physical inactivity is a major modifiable risk factor, while regular physical activity is associated with broad cardiometabolic benefits. Methods:This narrative review synthesises evidence from meta-analyses, randomised controlled trials, and mechanistic studies identified through PubMed, Scopus, Web of Science, and JACC. Studies evaluating aerobic, resistance, combined, and high-intensity interval training (HIIT) were included. Outcomes included cardiovascular risk factors, inflammation, metabolic health, cardiorespiratory fitness, and clinical endpoints. Results:Regular physical activity reduces systemic inflammation (CRP, IL-6, TNF-α), improves endothelial function, and enhances insulin sensitivity. Combined aerobic and resistance training provides superior improvements in glycaemic control, including HbA1c reductions (~0.5%), fasting glucose, and lipid profiles compared with single-modality exercise. Clinically relevant reductions in blood pressure are observed, particularly in hypertensive populations (systolic ~5–10 mmHg). Exercise improves lipid profiles (↑HDL, ↓LDL and triglycerides) and reduces visceral fat (~7–20%). Improvements in VO₂ peak are strongly associated with reduced cardiovascular morbidity and mortality. A dose–response relationship is evident, with optimal benefits at 150–300 min/week of moderate-intensity activity. Sedentary behaviour independently increases cardiovascular risk. Despite benefits, adherence remains suboptimal, although digital tools and personalised interventions improve compliance. Conclusion:Physical activity is a cornerstone of cardiovascular disease prevention and management, improving metabolic, inflammatory, and haemodynamic health. Individualised and technology-supported exercise strategies may enhance long-term adherence and maximise clinical benefit.
- Open Access
- 26 April 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 54
Caffeine in Sport: Performance Enhancer or Hidden Player in Cancer Biology? A Narrative Review
Caffeine is one of the most widely used ergogenic aids in sport, known for its performance-enhancing effects on endurance, strength, and cognitive function. Beyond these well-established roles, emerging evidence suggests that caffeine may also influence biological pathways associated with carcinogenesis. This narrative review provides a sports-oriented perspective on caffeine as a bioactive compound with potential implications extending beyond performance. Current evidence indicates that caffeine modulates mechanisms such as DNA damage response, apoptosis, oxidative stress, and immune regulation. While experimental findings suggest possible anticancer effects, human evidence remains inconsistent and largely observational. Given the widespread and repeated use of caffeine in athletic populations, understanding its broader biological impact is essential. Although caffeine cannot be considered an anticancer agent, its dual role in performance enhancement and health-related pathways highlights the need for integrative research bridging sports science and oncology.
- 26 April 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 54
Open AccessCaffeine in Sport: Performance Enhancer or Hidden Player in Cancer Biology? A Narrative Review
Caffeine is one of the most widely used ergogenic aids in sport, known for its performance-enhancing effects on endurance, strength, and cognitive function. Beyond these well-established roles, emerging evidence suggests that caffeine may also influence biological pathways associated with carcinogenesis. This narrative review provides a sports-oriented perspective on caffeine as a bioactive compound with potential implications extending beyond performance. Current evidence indicates that caffeine modulates mechanisms such as DNA damage response, apoptosis, oxidative stress, and immune regulation. While experimental findings suggest possible anticancer effects, human evidence remains inconsistent and largely observational. Given the widespread and repeated use of caffeine in athletic populations, understanding its broader biological impact is essential. Although caffeine cannot be considered an anticancer agent, its dual role in performance enhancement and health-related pathways highlights the need for integrative research bridging sports science and oncology.